HomePress-release

Redding, California - July 16, 2024

Multiplex Assays Market to be Worth $6.80 Billion by 2031

Multiplex Assays Market Size, Share, Forecast, & Trends Analysis by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Infectious) Product, End User - Global Forecast to 2031

Meticulous Research^®—a leading global market research company, published a research report titled, ‘Multiplex Assays Market Size, Share, Forecast, & Trends Analysis by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Infectious) Product, End User - Global Forecast to 2031.’

According to this latest publication from Meticulous Research^®, the multiplex assays market is projected to reach $6.80 billion by 2031 at a CAGR of 8.9%. The growth of this market is attributed to several factors: the advantages of multiplex assays over singleplex assays, the use of multiplexing in companion diagnostics, the increasing prevalence of chronic & infectious diseases, rising use of multiplex assays in drug discovery, and rising awareness about the importance of early disease diagnosis.

However, the high costs of multiplex assay equipment restrains the growth of this market. The growing need for high-throughput and automated laboratory systems and the increasing focus on personalized medicine are expected to generate growth opportunities for the players operating in this market. However, the shortage of skilled professionals and the risk of cross-reactivity are major challenges to market growth.

Key Players

The key players operating in the multiplex assays market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Seegene, Inc. (South Korea), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Illumina, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Quanterix Corporation (U.S.), DiaSorin S.p.A. (Italy), and Merck KGaA (Germany).

Multiplex Assays Market: Future Outlook

The multiplex assays market is segmented by Type (Protein Multiplex Assays [Bead-based Assays, Planar Assays], Nucleic Acid Multiplex Assays, Cell-based Multiplex Assays), Product (Consumables, Instruments, Software), Technology (Flow Cytometry, Multiplex Immunoassay, Multiplex Real-time PCR, Sequencing, Other Technologies), Application (Research & Development, Clinical Diagnosis [Infectious Diseases, Oncology, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases]) and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.

Among all types studied in this report, in 2024, the protein multiplex assays segment is expected to account for the largest share of 53.3% of the multiplex assays market. Protein multiplex assays are increasingly used to study protein pathways and biomarker development. Some application areas of protein multiplex assays are clinical biomarker development, comprehensive proteomic surveys, validation of genomic discoveries, and studies of protein networks and pathways. Protein assays are also used in clinical trials as they offer quick analysis, reduce labor costs, and decrease the chances of manual error, which increases research efficiency.

Among all products studied in this report, the consumables segment is expected to grow at the highest CAGR during the forecast period. The continuous advancements in the development of reagents and kits, the adoption of multiplex assays diagnostic kits for disease diagnosis, and ease of use are increasing the demand for consumables used in multiplex assays.

Among all technologies studied in this report, in 2024, the flow cytometry segment is expected to account for the largest share of 40.0% of the multiplex assays market. The large market share of this segment is attributed to factors such as the use of flow cytometry in clinical diagnosis for multiple pathogen detection and basic research, rapid multiparametric analysis, and technological advancements in flow cytometry.

Among all applications studied in this report, the research & development segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is attributed to increasing applications of multiplex assay in drug discovery, adoption of assays in biomarker profiling, and use of multiplex assays in understanding disease mechanisms.

Among all end users studied in this report, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the multiplex assays market. The large share of this segment is attributed to the increasing demand for new drugs and therapies, leading to extensive research & development activities, rising funding & investments in the pharmaceutical & biotech industry, and increasing healthcare expenditure. Furthermore, the pharmaceutical & biotechnology industries constantly strive to develop new drugs and therapies to address medical needs, further driving market growth.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa.

Among all regions studied in this report, Asia-Pacific is expected to grow at the highest CAGR of 10.8% during the forecast period. The growth of the region is attributed to advancements in healthcare infrastructure, development in the R&D sector, increasing number of diagnostic laboratories in the region, and advancements in the research sector in emerging economies of the region.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5598

Key questions answered in the report-

Which are the high-growth market segments in terms of type, product, technology, application, end user and regions/countries?
What was the historical market for multiplex assays across the globe?
What are the market forecasts and estimates for the period 2024–2031?
What are the major drivers, restraints, challenges, opportunities, and trends in the multiplex assays market?
Who are the major players in the multiplex assays market?
What is the competitive landscape, and who are the market leaders in the multiplex assays market?
What are the recent developments in the multiplex assays market?
What are the different strategies adopted by the major players in the multiplex assays market?
What are the geographical trends and high growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & Wastewater Technologies

Miscellaneous / Others

Redding, California - July 16, 2024

Multiplex Assays Market to be Worth $6.80 Billion by 2031

Multiplex Assays Market Size, Share, Forecast, & Trends Analysis by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Infectious) Product, End User - Global Forecast to 2031

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies